AdamL.BoxerMDPhD

Clinical Trials

• Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia Start of enrollment: 2007 Oct 01

  Completed

  Phase 4

• Davunetide (AL-108) in Predicted Tauopathies - Pilot Study Start of enrollment: 2010 Jan 01

  Completed

  Phase 1

• Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Start of enrollment: 2012 Jul 01

  Recruiting

• Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 Start of enrollment: 2012 Dec 01

  Recruiting

  Phase 2, Phase 3

• 4 Repeat Tauopathy Neuroimaging Initiative Start of enrollment: 2014 Jan 01

  Active, not recruiting

• Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations Start of enrollment: 2013 Mar 01

  Completed

  Phase 1

• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01

  Terminated

  Phase 3

• A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's Disease Start of enrollment: 2013 Nov 01

  Completed

  Phase 1

• Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28

  Completed

  Phase 3

• Safety Study of TPI-287 to Treat CBS and PSP Start of enrollment: 2014 May 01

  Completed

  Phase 1

• A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy Start of enrollment: 2015 Apr 01

  Completed

  Phase 1

• Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy Start of enrollment: 2015 Jul 01

  Completed

  Phase 1

• Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003 Start of enrollment: 2016 Feb 22

  Terminated

  Phase 1

• 4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2 Start of enrollment: 2016 Jan 01

  Active, not recruiting

• Intranasal Oxytocin for Frontotemporal Dementia Start of enrollment: 2018 Jan 31

  Active, not recruiting

  Phase 2

• Salsalate in Patients Mild to Moderate Alzheimer's Disease Start of enrollment: 2017 Jul 21

  Active, not recruiting

  Phase 1

• BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES Start of enrollment: 2018 Sep 12

  Terminated

  Phase 1

• Join now to see all